eMedicine Specialties > Neurology > Inflammatory and Demyelinating Diseases

Ankylosing Spondylitis: Follow-up

Author: Alan Schaffert, MD, Former Chief of Staff, Department of Medicine, Doctor's Medical Center of Modesto; Clinical Assistant Professor, University of California at Davis
Contributor Information and Disclosures

Updated: Jan 8, 2007

Follow-up

Complications

  • Atlantoaxial subluxation may occur spontaneously and can be associated with a severe myelopathy. It is found in about 20% of patients who have a mean disease duration of 10 years. Clinically significant myelopathy requiring fusion is found in only 2%.
  • Cervical spinal fractures are uncommon and usually are seen in patients with advanced disease.
    • Fracture usually results from minor trauma. Typically, the fracture is through the intervertebral space at level C5-C6 or C6-C7. Neurological deficits associated with spinal fracture may be delayed for 2-30 days.
    • Approximately 57% have severe neurological sequelae. Overall mortality rate is 35%, about twice that of a similar fracture in healthy individuals.
  • Cervical myelopathy may result from cervical spinal stenosis.
  • Thoracic and lumbar spinal fractures are less common than cervical spinal fractures. They usually result from minor trauma and may be multiple. Severe neurological deficits are frequent.
  • Lumbar spinal stenosis may result in a cauda equina syndrome.
    • Chronic inflammatory cauda equina syndrome occurs only in long-standing AS and may occur when other aspects of the disease are seemingly inactive.
    • Patient described a gradual onset of buttock and leg pain. Sensory symptoms are often mild and symmetrical, often not noticed by the patient.
    • Motor involvement and bowel or bladder dysfunction are variable.
    • This condition is slowly progressive to stable for years to decades.
    • Neither surgery nor steroid therapy is beneficial.
  • Radiculopathies may occur as a result of foraminal stenosis, disc disease, or fracture at the level of a nerve root.

Prognosis

  • Symptoms of pain and stiffness are common and may be moderately severe to severe. Patients have few problems with social interactions, although depression is common.
  • Most patients remain employed and relatively few develop severe functional disability. Disability correlates with duration of disease, disease activity, and spinal mobility. Peripheral joint involvement also results in greater impairment.
  • The medical cost of treating AS can be relatively low compared with the costs of other rheumatologic diseases. The use of tumor necrosis factor antagonist agents is very expensive.

Miscellaneous

Medicolegal Pitfalls

  • Angular kyphosis may result from a spinal fracture. Evaluation often requires imaging techniques, since neurological deficits may be delayed.
  • Nocturnal pain in a weight-bearing joint is atypical and should be evaluated.
  • Persistent neck or back pain after a seemingly minor trauma requires evaluation to rule out a fracture. Multiple fractures are a possibility, which may be difficult to see on a plain x-ray. Obtain CT or MRI scans and image the spine liberally to avoid missing an occult fracture.
  • With preexisting kyphosis, a suspected thoracolumbar fracture may be a contraindication to immobilization in the supine position. Severe neurological deficit may result.
 


More on Ankylosing Spondylitis

Overview: Ankylosing Spondylitis
Differential Diagnoses & Workup: Ankylosing Spondylitis
Treatment & Medication: Ankylosing Spondylitis
Follow-up: Ankylosing Spondylitis
References

References

  1. Boonen A, Van der Heijde D, Landewe R, et al. Costs of ankylosing spondylitis in three European countries: the patient's perspective. Ann Rheum Dis. Aug 2003;62(8):741-7. [Medline].

  2. Clegg DO. Treatment of ankylosing spondylitis. J Rheumatol Suppl. Sep 2006;78:24-31. [Medline].

  3. Dalyan M, Guner A, Tuncer S, et al. Disability in ankylosing spondylitis. Disabil Rehabil. Feb 1999;21(2):74-9. [Medline].

  4. Einsiedel T, Schmelz A, Arand M, et al. Injuries of the cervical spine in patients with ankylosing spondylitis: experience at two trauma centers. J Neurosurg Spine. Jul 2006;5(1):33-45. [Medline].

  5. Elyan M, Khan MA. Diagnosing ankylosing spondylitis. J Rheumatol Suppl. Sep 2006;78:12-23. [Medline].

  6. Fast A, Parikh S, Marin EL. Spine fractures in ankylosing spondylitis. Arch Phys Med Rehabil. Sep 1986;67(9):595-7. [Medline].

  7. Forouzesh S, Bluestone R. The clinical spectrum of ankylosing spondylitis. Clin Orthop Relat Res. Sep 1979;53-8. [Medline].

  8. Fox MW, Onofrio BM, Kilgore JE. Neurological complications of ankylosing spondylitis. J Neurosurg. Jun 1993;78(6):871-8. [Medline].

  9. Gordon AL, Yudell A. Cauda equina lesion associated with rheumatoid spondylitis. Ann Intern Med. Apr 1973;78(4):555-7. [Medline].

  10. Graham B, Van Peteghem PK. Fractures of the spine in ankylosing spondylitis. Diagnosis, treatment, and complications. Spine. Aug 1989;14(8):803-7. [Medline].

  11. Murray GC, Persellin RH. Cervical fracture complicating ankylosing spondylitis: a report of eight cases and review of the literature. Am J Med. May 1981;70(5):1033-41. [Medline].

  12. Ramos-Remus C, Gomez-Vargas A, Guzman-Guzman JL, et al. Frequency of atlantoaxial subluxation and neurologic involvement in patients with ankylosing spondylitis. J Rheumatol. Nov 1995;22(11):2120-5. [Medline].

  13. Reveille JD, Arnett FC. Spondyloarthritis: update on pathogenesis and management. Am J Med. Jun 2005;118(6):592-603. [Medline].

  14. Russell ML, Gordon DA, Ogryzlo MA, McPhedran RS. The cauda equina syndrome of ankylosing spondylitis. Ann Intern Med. Apr 1973;78(4):551-4. [Medline].

  15. Spoorenberg A, Van der Heijde D, de Klerk E, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol. Apr 1999;26(4):980-4. [Medline].

  16. Trent G, Armstrong GW, O'Neil J. Thoracolumbar fractures in ankylosing spondylitis. High-risk injuries. Clin Orthop Relat Res. Feb 1988;227:61-6. [Medline].

  17. Tyrrell PN, Davies AM, Evans N. Neurological disturbances in ankylosing spondylitis. Ann Rheum Dis. Nov 1994;53(11):714-7. [Medline].

  18. Ward MM. Quality of life in patients with ankylosing spondylitis. Rheum Dis Clin North Am. Nov 1998;24(4):815-27, x. [Medline].

  19. Zochling J, van der Heijde D, Burgos-Vargas R, et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. Apr 2006;65(4):442-52.

  20. van der Linden S, van der Heijde D. Ankylosing spondylitis. Clinical features. Rheum Dis Clin North Am. Nov 1998;24(4):663-76, vii. [Medline].

Further Reading

Keywords

ankylosing spondylitis, Marie-Strümpell arthritis, Bechterew disease, spondyloarthritis, spondyloarthropathy, chronic inflammatory conditions, AS, inflammation of the joints, inflammation of the tendons, inflammation of the ligaments, iritis, uveitis, aortitis, pulmonary fibrosis, amyloidosis, inflammatory bowel disease

Contributor Information and Disclosures

Author

Alan Schaffert, MD, Former Chief of Staff, Department of Medicine, Doctor's Medical Center of Modesto; Clinical Assistant Professor, University of California at Davis
Alan Schaffert, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, California Medical Association, and National Stroke Association
Disclosure: Nothing to disclose.

Medical Editor

Rodrigo O Kuljis, MD, Esther Lichtenstein Professor of Psychiatry and Neurology, Director, Division of Cognitive and Behavioral Neurology, Department of Neurology, University of Miami School of Medicine
Rodrigo O Kuljis, MD is a member of the following medical societies: American Academy of Neurology and Society for Neuroscience
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Florian P Thomas, MD, MA, PhD, Drmed, Director, Spinal Cord Injury Unit, St Louis Veterans Affairs Medical Center; Director, National MS Society Multiple Sclerosis Center; Associate Program Director, Professor, Department of Neurology and Psychiatry, Associate Professor, Institute for Molecular Virology, and Department of Molecular Microbiology and Immunology, St Louis University
Florian P Thomas, MD, MA, PhD, Drmed is a member of the following medical societies: American Academy of Neurology, American Paraplegia Society, and National Multiple Sclerosis Society
Disclosure: Nothing to disclose.

CME Editor

Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital
Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants
Nicholas Y Lorenzo, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Neurology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.